Åström Hanne, Wester Axel, Hagström Hannes
Department of Medicine, Karolinska Institutet, Huddinge, Stockholm, Sweden.
Division of Hepatology, Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden.
Scand J Gastroenterol. 2023 Jul-Dec;58(8):931-936. doi: 10.1080/00365521.2023.2185475. Epub 2023 Mar 8.
Epidemiological studies of non-alcoholic fatty liver disease (NAFLD) frequently use the International Classification of Disease (ICD) codes to identify patients. The validity of such ICD codes in a Swedish setting is unknown. Here, we aimed to validate the administrative code for NAFLD in Sweden. In total, 150 patients with an ICD-10 code for NAFLD (K76.0) from the Karolinska University Hospital between 1 January 2015 and 3 November 2021 were randomly selected. Patients were classified as true or false positives for NAFLD by medical chart review and the positive predictive value (PPV) for the ICD-10 code corresponding to NAFLD was calculated. The PPV of the ICD-10 code for NAFLD was 0.82 (95% confidence interval [CI] = 0.76-0.89). After exclusion of patients with diagnostic coding for other liver diseases or alcohol abuse disorder ( = 14), the PPV was improved to 0.91 (95% CI 0.87-0.96). The PPV was higher in patients with coding for NAFLD in combination with obesity (0.95, 95%CI = 0.87-1.00) or type 2 diabetes (0.96, 95%CI = 0.89-1.00). However, in false-positive cases, a high alcohol consumption was common and such patients had somewhat higher Fibrosis-4 scores than true-positive patients (1.9 vs 1.3, = 0.16) The ICD-10 code for NAFLD had a high PPV, that was further improved after exclusion of patients with coding for other liver diseases than NAFLD. This approach should be preferred when performing register-based studies to identify patients with NAFLD in Sweden. Still, residual alcohol-related liver disease might risk confound some findings seen in epidemiological studies which needs to be considered.
非酒精性脂肪性肝病(NAFLD)的流行病学研究经常使用国际疾病分类(ICD)编码来识别患者。在瑞典背景下,此类ICD编码的有效性尚不清楚。在此,我们旨在验证瑞典NAFLD的行政编码。总共从卡罗林斯卡大学医院随机选取了2015年1月1日至2021年11月3日期间有ICD - 10编码为NAFLD(K76.0)的150名患者。通过病历审查将患者分类为NAFLD的真阳性或假阳性,并计算与NAFLD相对应的ICD - 10编码的阳性预测值(PPV)。NAFLD的ICD - 10编码的PPV为0.82(95%置信区间[CI]=0.76 - 0.89)。排除有其他肝病或酒精滥用障碍诊断编码的患者(n = 14)后,PPV提高到0.91(95% CI 0.87 - 0.96)。在伴有肥胖(0.95,95% CI = 0.87 - 1.00)或2型糖尿病(0.96,95% CI = 0.89 - 1.00)的NAFLD编码患者中,PPV更高。然而,在假阳性病例中,高酒精摄入量很常见,且此类患者的纤维化 - 4评分略高于真阳性患者(1.9对1.3,P = 0.16)。NAFLD的ICD - 10编码具有较高的PPV,在排除非NAFLD的其他肝病编码患者后进一步提高。在瑞典进行基于登记的研究以识别NAFLD患者时,应优先采用这种方法。尽管如此,残留的酒精性肝病可能会混淆流行病学研究中的一些发现,这一点需要考虑。